SYMPROIC is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Shionogi Inc.. The primary component is Naldemedine Tosylate.
| Product ID | 59630-222_41985d7d-0aa5-4ca5-a730-997330c1108e |
| NDC | 59630-222 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SYMPROIC |
| Generic Name | Naldemedine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-03-23 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208854 |
| Labeler Name | Shionogi Inc. |
| Substance Name | NALDEMEDINE TOSYLATE |
| Active Ingredient Strength | 0 mg/1 |
| Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-07-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208854 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-07-05 |
| Marketing End Date | 2020-12-31 |
| Marketing Category | NDA |
| Application Number | NDA208854 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-07-05 |
| Marketing End Date | 2020-12-31 |
| Marketing Category | NDA |
| Application Number | NDA208854 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-07-05 |
| Marketing End Date | 2020-12-31 |
| Ingredient | Strength |
|---|---|
| NALDEMEDINE TOSYLATE | .2 mg/1 |
| SPL SET ID: | 12ca7d88-2a0c-4c3b-b61e-f58849c7e9e3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59011-523 | Symproic | naldemedine |
| 59385-041 | SYMPROIC | naldemedine tosylate |
| 59630-222 | SYMPROIC | naldemedine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SYMPROIC 79168243 4887392 Live/Registered |
SHIONOGI & CO., LTD. 2015-01-27 |